Neuropace, INC.:1336391 [26-001427]
Active Purchase Order Awarded
- Contract number
- 75N90026P00037
- Awardee
-
Neuropace Inc. UEI VV9XSUEG8QD3
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $115,286
Award facts
- Contract value 100% obligated
- $115,286.25 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mountain View, CA 94043, USA
Award details come from SAM.gov/FPDS.
About this award
Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems for neurological disorders, was awarded a $115,286.25 firm fixed-price purchase order by the National Institutes of Health Clinical Center on December 30, 2025. The contract, which carries an ultimate completion date of December 29, 2026, represents a direct procurement with no set-aside designation. Based on Neuropace's established federal contracting history, this purchase order likely involves the supply of neurostimulation devices, surgical implants, electrodes, and related accessories to support clinical operations at the NIH Clinical Center.
The award aligns with Neuropace's core competency in providing specialized medical devices for treating seizure disorders and other neurological conditions. The company has maintained an established relationship with federal health agencies, particularly through prior contracts with the Department of Veterans Affairs and ongoing collaboration with the National Institute of Neurological Disorders and Stroke on advanced research initiatives focused on responsive neurostimulation therapies. This purchase order supports the Clinical Center's procurement needs while leveraging Neuropace's expertise in developing and delivering innovative neurostimulation technologies to federal medical facilities.
Quick answers
Who was awarded contract 75N90026P00037?
75N90026P00037 was awarded to Neuropace Inc. by NIH Clinical Center (National Institutes of Health) on December 30, 2025.
How much is contract 75N90026P00037 worth?
The government has obligated $115,286 on 75N90026P00037.
Was contract 75N90026P00037 competed?
The extent of competition for 75N90026P00037 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award